Results 91 to 100 of about 76,302 (279)

Cardiovascular Health in Women—Across the Lifespan

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar   +5 more
wiley   +1 more source

Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry

open access: yesClinical and Experimental Neuroimmunology, EarlyView.
ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa   +2 more
wiley   +1 more source

Case Report of Long QT Syndrome in a Patient With Syncope

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Chun‐Yu Chen   +3 more
wiley   +1 more source

Status quo and future developments in the diagnosis and treatment of hereditary angioedema

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Hereditary angioedema (HAE) is a rare hereditary disease characterized by edema, which can be life‐threatening in case of swelling in the larynx. The most common form of HAE is caused by a mutation of the SERPING1 gene and is characterized by a deficiency (type I) or loss of function (type II) of the C1 inhibitor (C1‐INH), leading to excessive ...
Andreas Recke
wiley   +1 more source

Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims This study aimed to evaluate the efficacy and safety of triple therapy with lobeglitazone 0.5 mg as an add‐on treatment compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and empagliflozin.
Da Hea Seo   +8 more
wiley   +1 more source

Machine learning‐based prediction of atrial fibrillation in patients with atrial high‐rate episodes

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Abstract Background Given the modest performance of available predictive models in estimating the risk of atrial fibrillation (AF) in patients with atrial high‐rate episodes (AHREs) detected by cardiac implantable electronic devices (CIEDs), this study explores the potential use of machine learning (ML) algorithms in this context. Purpose To assess the
Amir Askarinejad   +9 more
wiley   +1 more source

The perception of palpitations and its risk factors among general population in the western region of Saudi Arabia: A cross-sectional study [PDF]

open access: bronze, 2023
Majid H Ali   +6 more
openalex   +1 more source

Psychogenic Urinary Frequency and the Role of Kampo Medicine: Addressing Limitations of SSRI Therapy in Panic Disorder

open access: yes
Traditional &Kampo Medicine, EarlyView.
Kazuyoshi Johnin   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy